| Identification | Back Directory | [Name]
Amrubicinhydrochloride | [CAS]
92470-31-0 | [Synonyms]
Amrubicin HCL
Cis-Amrubicin Hydrochloride
(7S-cis)-9-Acetyl-9-amino-7-[(2-deoxy-alpha-D-erythro-pentopyranosyl)oxy]-7,8,9,10-tetrahydro-6,11-dihydroxy-5,12-naphthacenedione hydrochloride | [Molecular Formula]
C25H25NO9.HCl | [MDL Number]
MFCD00876391 | [MOL File]
92470-31-0.mol | [Molecular Weight]
519.93 |
| Questions And Answer | Back Directory | [Uses]
Amrubicin hydrochloride is a novel, chemically synthesized anthracycline-based anti-cancer drug developed by Dainippon Sumitomo Pharma Co., Ltd. of Japan. It is characterized by its 9-position amino and sugar structure. Clinically, it is used to treat non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). |
|
| Company Name: |
NCE Biomedical Co.,Ltd.
|
| Tel: |
4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988 |
| Website: |
www.chemicalbook.com/ShowSupplierProductsList15748/0_EN.htm |
|